El Hospital Nacional Dos de Mayo es el primer centro hospitalario público peruano administrado por el Ministerio de Salud del Perú, considerado como el primer hospital del Perú republicano.

During the past decade, Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia" are "Alzheimer Disease" (2 trials), "Multiple Sclerosis" (2 trials), "Alzheimer's Disease" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Antihistamine" (2 trials), "Gantenerumab" (2 trials), "Methylprednisolone" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Dos de Mayo; Unidad de Investigacion de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".